Intended for healthcare professionals

A spot of Savin: Can we beat pemphigus?

John Savin
If you read only one scientific paper this year, make it the one listed below – by Proby et al. It contains a strikingly original idea on how to deal with pemphigus. Admittedly you may find the paper fairly hard work; one sentence in the summary, for example, runs: ‘The epitopes of these monoclonal antibodies were mapped on the amino terminal EC1 and part of EC2, a region considered functionally important in cadherins’. Your best plan is probably to read first the commentary on the paper that the editors of the British Journal of Dermatology have thoughtfully provided. If you find this difficult too, then simply plough on to the end of this page.
Dermatology in practice 2000; 8(3): 31–31
To continue reading this article, please sign in or register.

Dermatology in practice was previously supported by Wyeth from 2008 to 2010, by Wyeth and Serono in 2007, by Wyeth and Shire from 2005 to 2006, by Medlock Medical in 2004 and by SSL International from 2001 to 2003.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the publisher, Editor or Editorial Board. Accordingly the publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Dermatology in practice is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2021 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to:

ISSN 0262-5504 (Print) ISSN 2049-8446 (Online)